Loading organizations...
Arbor Ventures is a global venture capital firm focused exclusively on the fintech sector, supporting companies building and digitizing next-generation financial infrastructure. The firm partners with early-stage enterprises, applying deep industry expertise to foster growth and scale across key markets in Asia, the Middle East, Europe, and the United States.
Founded in 2012 by Melissa Guzy and Wei Hopeman, Arbor Ventures originated from their combined extensive experience in finance and venture capital. Guzy's technology investing background and Hopeman's tenure at Citi Ventures provided critical insight into fintech's transformative potential, leading them to establish the firm to guide innovators.
Arbor Ventures targets entrepreneurs developing solutions to redefine the financial landscape. Its vision is to cultivate a smarter future by empowering these pioneering companies, contributing to a more efficient and accessible global financial ecosystem.
Arbor Capital has 1 tracked investment across 1 company. The latest tracked deal is $3.0M Series A in Specialty Renal Products(SRP) in September 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 6, 2018 | Specialty Renal Products(SRP) | $3.0M Series A | Arbor Capital, Wexford Capital | — |